Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $158.32M.
ENTERPRISE VALUE (EV)
$158.32M
Capricor Therapeutics, Inc.
Market Cap
$442.54M
Enterprise Value (EV)
$158.32M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $442.54M | $158.32M |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.53M | $411.59M |
| NeuroPace, Inc. (NPCE)vs › | $444.17M | $501.56M |
| NeoGenomics, Inc. (NEO)vs › | $438.49M | $741.31M |
| Editas Medicine, Inc. (EDIT)vs › | $438.47M | $272.17M |
| Ovid Therapeutics Inc. (OVID)vs › | $450.74M | $452.12M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $452.78M | $447.83M |
| NRC Health (NRC)vs › | $457.53M | $544.23M |
| Prothena Corporation plc (PRTA)vs › | $422.75M | $141.55M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $416.59M | $525.79M |
Market Cap
$442.54M
Total Debt
$3.62M
Cash
$287.85M
Enterprise Value
$158.32M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
